Tasly Holding Group

Tasly Holding Group, established in 1994, is an international high-tech enterprise primarily focused on the pan-health industry, with biological medicine as its core business. The company is committed to integrating traditional Chinese medicine (TCM) with modern health solutions, promoting a philosophy that emphasizes the harmony between humans and nature to enhance the quality of life. Tasly operates across six key sectors: bio-pharmaceuticals, health products, herbs, medical services, health management, and children's education. It has made significant strides in the international market, exporting over 30 types of preparations in eight medical categories to 23 countries across America, Europe, Africa, and Asia. Tasly's global distribution network spans more than 40 countries, supported by nearly a million distributor members worldwide. The company has been recognized as one of the top exporters of TCM in China and has appeared in the list of the Top 500 Chinese Enterprises by Fortune magazine.

Yan XiJun

Founder and President

20 past transactions

Tokyo Lifestyle

Debt Financing in 2024
Tokyo Lifestyle is a import and retail of Japanese beauty and cosmetic products and operates live e-commerce business.

Hegea Bio

Series A in 2024
Hegeia Biotechnology is a company that focused on the research and development of siRNA, tiny nucleic acid attached delivery medicines.

Hengyu Medical

Venture Round in 2024
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Yuanyi Biotech

Series A in 2023
Yuanyi Biotech is specialized in creating artificial microbial technology and products. It designs and builds new gene metabolic pathways using "engineering" thinking and effective gene editing tools, creating cell factories with extremely high productivity, and offering one-stop solutions for integrated strain development, fermentation process optimization, industrial fermentation production, and product development.

Hengyu Medical

Series C in 2023
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Hengyu Medical

Series C in 2022
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.

Micot

Series B in 2021
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

Global Health Ark Medical Technology

Series A in 2021
Ghalife is a medical device company integrating research and development, production, and sales. It is a research and industrial production that involves the development of medical devices. It involves the detection of non-invasive physiological parameters of the human body and is committed to building a chronic disease management system.

Avicanna

Post in 2020
Avicanna Inc. is a biopharmaceutical company based in Toronto, Canada, that specializes in the research, development, and commercialization of plant-derived cannabinoid-based products for medical, consumer health, and pharmaceutical applications. Founded in 2016, Avicanna offers a range of products, including pharmaceutical-grade cannabinoids such as THC, CBD, and CBG, as well as active pharmaceutical ingredients and formulations under its Aureus Santa Marta brand. The company also develops CBD-based derma-cosmetic products under the Pura Earth brand and medical cannabis products for various health conditions, including skin disorders and neurological issues, marketed under the Rho Phyto brand. Avicanna emphasizes scientific research and has collaborations with leading academic institutions to advance its cannabinoid-based solutions. The company’s research initiatives include a focus on developing treatments for COVID-19 induced lung inflammation. With a commitment to evidence-based practices, Avicanna aims to provide innovative cannabinoid solutions to the global market.

Zhangshang Tangyi

Series D in 2020
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Anovent Pharmaceutical

Venture Round in 2019
Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.

Micot

Seed Round in 2019
Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

HOZ Medical

Angel Round in 2018
HOZ Medical is a Beijing-based company that specializes in the development of neurosurgical robots aimed at enhancing the precision of brain surgeries. Founded in 2000, the company focuses on the clinical application of frameless stereotactic radiosurgery in neurosurgery. Its flagship product, the CAS-R-2, is a frameless brain stereotactic system designed to assist surgeons in planning and navigating craniocerebral procedures with improved accuracy through its three-dimensional orientation capabilities. By innovating in this field, HOZ Medical aims to advance surgical techniques and outcomes in neurosurgery.

Shequ580

Series A in 2018
Shequ580 is an online healthcare services platform based in Guangzhou, China, founded in 2015. The platform connects doctors with residents, facilitating the booking of consultations and offering a comprehensive family doctor service management system. It provides a range of features including a home doctor workbench that supports signing functions, statistical analysis tools, and real-time communication between doctors and patients. Additionally, it manages service processes such as inoculation appointments, health monitoring, and two-way referrals, while ensuring data security through integrated cloud protection and firewalls. Shequ580's focus is on delivering primary healthcare services to families, streamlining hospital management and enhancing the overall medical treatment experience for residents.

Genova

Corporate Round in 2017
Genova (Changzhou) Biotechnology Co., Ltd. is a biotechnology company based in Changzhou, China, specializing in the development and manufacturing of insulin products. The company is dedicated to producing advanced insulin formulations aimed at treating diabetes, cardiovascular, and cerebrovascular diseases, as well as tumors. Genova focuses on providing third-generation insulin drugs to enhance patient care and improve treatment outcomes.

ZYBC

Angel Round in 2017
ZYBC engages in the materials testing, evaluation & certification, and technical advisory services for traditional Chinese medicine.

PegBio

Series E in 2017
Founded in 2008 and based in Suzhou, PegBio is a biopharmaceutical company focused on developing innovative treatments for diabetes and obesity. The company's flagship product, PB-119, is a glucagon-like peptide 1 (GLP-1) agonist designed to improve the management of diabetes by allowing patients to take medication once a week, in contrast to the daily injections typically required. PegBio's research extends beyond diabetes, encompassing areas such as nonalcoholic fatty liver disease, gout, cardiovascular conditions, and cancer. The company aims to address significant health challenges through its advanced drug discovery efforts.

LenoMed Medical

Series A in 2017
LenoMed Medical is a manufacturer of medical devices focused on improving diabetes management. With over 15 years of research and development experience in infusion technology, the company specializes in creating innovative products such as the InnoTech insulin pump, drug infusion pumps, and related disposables. LenoMed is dedicated to enhancing diabetes care through the integration of continuous glucose monitoring technology with their insulin pumps, aiming to provide patients with better treatment options and monitoring capabilities. Their commitment to advancing diabetes management is reflected in their comprehensive diabetes care management system.

AccuRad

Series B in 2016
Xi'an AccuRad Network & Technology Co. Ltd. specializes in medical imaging technologies, emphasizing cloud-based solutions for medical image processing and analysis. Founded in 2001 and headquartered in Xi'an, China, with an additional branch in Guangzhou, the company offers a range of services, including image data cloud services, clinical image collaboration, and a comprehensive medical technology operation system. Its platform supports clinical images big data and fosters collaboration among medical institutions through an independent imaging center cloud platform. AccuRad also provides medical live video services, video on demand, and a social platform for doctors to share experiences, thereby enhancing diagnostic efficiency and quality in healthcare settings.

SHU LIAN YI KANG

Series A in 2016
Chengdu Shulian Yikang Technology is a third-party company that offers medical insurance services based on big data. They provide services such as intelligent auditing, policy-making auxiliary decision-making, and medical behavior supervision for local human resources, health, and family planning committees.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.